• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Cyclin-dependent kinases regulatory subunit 2 (CKS2)

ACP04989

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP04989 Target NameCKS2
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range1-79aaMol Weight17.3 kDa
Protein LengthFull lengthPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP33552
Background Information
  • Uniprot Id

    P33552

  • Target Species

    Human

  • Target Name

    CKS2

  • Target Full Name

    Cyclin-dependent kinases regulatory subunit 2

  • Target Function

    Binds to the catalytic subunit of the cyclin dependent kinases and is essential for their biological function.

  • Target Protein Families

    CKS family

  • Target Research Area

    Cell Biology

  • Target Synonyms

    CDC28; CDC28 protein kinase 2; CDC28 protein kinase regulatory subunit 2; CKS 2; CKS-2; CKS1(S. cerevisiae Cdc28/Cdc2 kinase subunit) homolog 2; Cks2; CKS2_HUMAN; CKSHS2; Cyclin dependent kinases regulatory subunit 2; Cyclin-dependent kinases regulatory subunit 2

  • Target Background

    CKS2 protein binds to the catalytic subunit of the cyclin dependent kinases and is essential for their biological function. The CKS2 mRNA is found to be expressed in different patterns through the cell cycle in HeLa cells, which reflects specialized role for the encoded protein.

Inquire Recombinant Human Cyclin-dependent kinases regulatory subunit 2 (CKS2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification